Zervalx™ is indicated for the distinct nutritional requirements of preconception and pregnant women who require increased folate concentrations, in the plasma and/or red blood cells (RBC), regardless of MTHFR C677T polymorphism genotype, with particular emphasis, for preconception and pregnant women over 35 years of age, and/or who are associated with intermediate- to higher- risk pregnancies.10,11,12,13 and/or who have preconception hyperhomocysteinemia14,15,16. Zervalx™ can be used prior to conception.17,18 throughout pregnancy, the postnatal period19 or while taking oral contraceptives to improve nutritional folate concentrations.20,21
Zervalx™ is indicated for the distinct nutritional requirements of patients, regardless of folate MTHFR 677C->T polymorphism genotype.22,23,24; who present with hemolytic, megaloblastic, and/or sickle cell anemia, complicated by folate deficiency25,26,27,28; and/or experience methotrexate induced plasma hyperhomocysteinemia28,29,30,31.
Use with Zervalx™ should always occur under the care of a physician.